According to Agenus 's latest financial reports the company's current EPS (TTM) is -$0.85. In 2022 the company made an earnings per share (EPS) of -$0.79 a decrease over its 2021 EPS that were of -$0.18.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.85 | 7.59% |
2022 | -$0.79 | 338.89% |
2021 | -$0.18 | -82.86% |
2020 | -$1.05 | 32.91% |
2019 | -$0.79 | -45.89% |
2018 | -$1.46 | 19.67% |
2017 | -$1.22 | -17.01% |
2016 | -$1.47 | 27.83% |
2015 | -$1.15 | 69.12% |
2014 | -$0.68 | -40.87% |
2013 | -$1.15 | 134.69% |
2012 | -$0.49 | -59.5% |
2011 | -$1.21 | -14.18% |
2010 | -$1.41 | -41.25% |
2009 | -$2.40 | -20% |
2008 | -$3.00 | -38.27% |
2007 | -$4.86 | -29.57% |
2006 | -$6.90 | -29.88% |
2005 | -$9.84 | 29.13% |
2004 | -$7.62 | -25.29% |
2003 | -$10.20 | -0.58% |
2002 | -$10.26 | -33.72% |
2001 | -$15.48 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $4.97 | -684.93% | ๐บ๐ธ USA |
![]() Merck MRK | $1.23 | -244.71% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $3.78 | -544.71% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $8.34 | -1,080.81% | ๐ฌ๐ง UK |
![]() Celldex Therapeutics CLDX | -$2.40 | 182.35% | ๐บ๐ธ USA |